Reduced intestinal FADS1 gene expression and plasma omega-3 fatty acids following Roux-en-Y gastric bypass (2019)
- Authors:
- USP affiliated authors: TORRINHAS, RAQUEL SUSANA MATOS DE MIRANDA - FM ; SAKAI, PAULO - FM ; SANTO, MARCO AURELIO - FM ; GIANNELLA, MARIA LUCIA CARDILLO CORREA - FM ; WAITZBERG, DAN LINETZKY - FM
- Unidade: FM
- DOI: 10.1016/j.clnu.2018.05.011
- Subjects: DERIVAÇÃO GÁSTRICA; ÁCIDOS GRAXOS OMEGA 3; EXPRESSÃO GÊNICA; SISTEMA GASTROINTESTINAL
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Clinical nutrition
- ISSN: 0261-5614
- Volume/Número/Paginação/Ano: v. 38, n. 3, p. 1280-1288, 2019
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
GARLA, Priscila et al. Reduced intestinal FADS1 gene expression and plasma omega-3 fatty acids following Roux-en-Y gastric bypass. Clinical nutrition, v. 38, n. 3, p. 1280-1288, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.clnu.2018.05.011. Acesso em: 13 fev. 2026. -
APA
Garla, P., Sala, P., Torrinhas, R. S. M. de M., Machado, N. M., Fonseca, D. C., Silva, M. M. da, et al. (2019). Reduced intestinal FADS1 gene expression and plasma omega-3 fatty acids following Roux-en-Y gastric bypass. Clinical nutrition, 38( 3), 1280-1288. doi:10.1016/j.clnu.2018.05.011 -
NLM
Garla P, Sala P, Torrinhas RSM de M, Machado NM, Fonseca DC, Silva MM da, Ravacci GR, Sakai P, Santo MA, Giannella MLCC, Waitzberg DL. Reduced intestinal FADS1 gene expression and plasma omega-3 fatty acids following Roux-en-Y gastric bypass [Internet]. Clinical nutrition. 2019 ; 38( 3): 1280-1288.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1016/j.clnu.2018.05.011 -
Vancouver
Garla P, Sala P, Torrinhas RSM de M, Machado NM, Fonseca DC, Silva MM da, Ravacci GR, Sakai P, Santo MA, Giannella MLCC, Waitzberg DL. Reduced intestinal FADS1 gene expression and plasma omega-3 fatty acids following Roux-en-Y gastric bypass [Internet]. Clinical nutrition. 2019 ; 38( 3): 1280-1288.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1016/j.clnu.2018.05.011 - Genetic reprogramming of rHemnant duodenum may contribute to type 2 diabetes improvement after Roux-en-Y gastric bypass
- Gastrointestinal genetic reprogramming of vitamin A metabolic pathways in response of Roux-en-Y gastric bypass
- Gastrointestinal Transcriptomic Response of Metabolic Vitamin B12 Pathways in Roux-en-Y Gastric Bypass
- Intestinal expression of toll-like receptor gene changes early after gastric bypass surgery and association with type 2 diabetes remission
- Cholecystectomy - a potential selection bias in studies assessing the metabolic effects of bariatric surgeries
- Type 2 diabetes metabolic improvement after roux-en-Y gastric bypass may include a compensatory mechanism that balances fatty acid beta and omega oxidation
- The SURMetaGIT study: design and rationale for a prospective pan-omics examination of the gastrointestinal response to Roux-en-Y gastric bypass surgery
- Dietary intake of AIN-93 standard diet induces fatty liver with altered hepatic fatty acid profile in Wistar rats [Carta]
- Response to Bistrian BR. Parenteral Fish-Oil Emulsions in Critically Ill COVID-19 Emulsions
- High-Fiber Orange Juice as a Nutrition Supplement in Women: A Randomized, Double-Blind, Placebo-Controlled Study of Tolerance and Effectiveness
Informações sobre o DOI: 10.1016/j.clnu.2018.05.011 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
